newsmantra.in l Latest news on Politics, World, Bollywood, Sports, Delhi, Jammu & Kashmir, Trending news | News Mantra
Business

TRANSLINE TECHNOLOGIES LIMITED FILES DRHP WITH SEBI 

TRANSLINE TECHNOLOGIES LIMITED FILES DRHP WITH SEBI 

Bangalore, 11 August 2025 – Transline Technologies Limited (“the Company”),  a specialized technology-solutions provider with a focus on designing, developing, and deploying integrated security and surveillance systems, biometric authentication platforms, and artificial intelligence-driven software products has filed its Draft Red Herring Prospectus (“DRHP”) with market regulator Securities and Exchange Board of India (“SEBI”). 

The Company plans to raise funds through equity share capital via initial public offering. The total offer size of initial public offer comprises of ‘Offer for Sale’ of up to 16,191,500 equity shares with face value Rs.2 each share.

Transline Technologies’ business model generates revenue from multiple streams, including project-based system integration contracts, Software as a Service (“SaaS”) subscriptions, sale of hardware and software products, and technical services such as annual maintenance and managed support. Company has developed a portfolio of proprietary software tools—StorePulse, an AIpowered video analytics platform —StorePulse, an AIpowered video analytics platform; CamStore, a real-time video compression and storage optimization solution; and CheckCam, a CCTV network health monitoring system—which are offered as standalone cloud-deployed SaaS solutions or as part of integrated turnkey deployments

Motilal Oswal Investment Advisors Limited is the sole Book Running Lead Managers (BRLMs) to the issue.

Related posts

Chief Minister of Madhya Pradesh Attended Rajasthan DigiFest × TiE Global Summit 2026

Newsmantra

The Premia Academy receives Prestigious Education World Award for Student Leadership & Skill Development

Newsmantra

SAIL declares financial results for 9M FY’26 

Newsmantra

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More